Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

Wonder if this was walked up by the MMs on the back of SEO success to shift stock? Following a good start to the day, on the way back down now. There certainly hasn't been anything to support the recent rise.

PTH

I wouldn't be surprised at all if it goes to 44p today, I am talking
to short termers only.

Buyers are back, I think its good time to buy/top up NOW.

For those still holding BPRG and/or bought during in following the recent drop, a spot of hope.


CEO Appointment
BioProgress plc (AIM: BPRG; NASDAQ: BPRG), the provider of innovative delivery mechanisms for the pharmaceutical oral dosage markets, announces the appointment of Richard Trevillion as Chief Executive Officer.

Mr Trevillion joined the Board as a Non-Executive Director in February 2005 and became interim Chief Executive at the end of April. He has a wide range of experience within the global healthcare and technology sectors, both as advisor and principal, and has been responsible for the development of a number of high growth technology businesses.

****************************
Commenting on his appointment, Richard Trevillion said: I am delighted to accept the invitation of the Board to become CEO of BioProgress. The Company has a strong suite of technology and intellectual property, combined with a highly motivated team of professionals dedicated to the further commercialisation and development of the business.


****************BioProgress has a strong balance sheet **********************
and international presence which we will use as a solid foundation to move the business forward to the next stages of growth and development.
*********************************
The financial and strategic review will be completed by the end of this month, and the Board will provide shareholders with a report on the principal conclusions as soon as possible.


Forward-Looking Information.

The Ordinary Shares of BioProgress plc are registered under the US Securities and Exchange Act of 1934. To the extent that this announcement contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, this paragraph applies. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements in this release include statements addressing future financial and operating results and the timing and benefits of the reorganisation. Detailed information about factors pertinent to the business of the company that could cause actual results to differ is set forth in the Companys filings with the Securities and Exchange Commission. The Company is under no obligation to (and expressly disclaim any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise. This announcement is for information only and does not constitute an offer or invitation to acquire or dispose of any securities or investment advice. The distribution of the announcement and/or issue of securities in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about and to observe such restrictions.

Enquiries:

BioProgress plc


Richard Trevillion, CEO
Tel: +44 (0) 1354 655674


www.bioprogress.com


UK Media enquiries: Abchurch


Samantha Robbins
Tel: +44 (0) 20 7398 7700

samantha.robbins@abchurch-group.com
www.abchurch-group.com


US Investor enquiries: Taylor Rafferty


Andrew Saunders
Tel: +1 212 889 4350

andrew.saunders@taylor-rafferty.com
www.taylor-rafferty.com


For further information, contact us.

Where have the rampers gone like "good news" hyleo ?

Crock of sh*te ... 22p next stop.

Dil I don't think I would short this now. I think this drop back is due to change of CEO and appraisal which seems ?fair. As before it will be a slow return to the crazy heights of before. But the "products" are useful and required in the medical field.

May be wrong but I will hold what I got for a tad longer.

dragged down by fall in drugs market

The change in CEO was positive news Fred. My sentiments are the opposite , I wouldn't like to be long with the amount of uncertainty knocking about.

38p had to hole methinks. Might be looking to return to 30-32p soon?

This afternoon would be nice Al ... I would overtake Kayak in the Champions investor game then :-)

LOVELY NEWS I THINK,AND LOOK AT THE PRICE AS ITS RECOVERED SOME WHAT FROM TODAYS LOWS.

DIl were you shot sorry short?

LOL Fred.

Seriously question - how many more deals such as today's might they have? Would be worth a quick calculation. Can't see that buying all this stuff back and issuing more shares is that clever short to medium term, but there are others far better than me at working this stuff out.

Cheers,
Al
;-)

Many times Fred , in out in out ... shake it all about :-)

Wondered why they went up a bit yesterday Al but couldn't be ar*ed to look , they signed another deal thats going to revolutionise the world then ?

Al , if you bought 5million of convertable bonds the sold them back 8 months later for the equivalent of 3.3million (half cash / half shares) then I would suggest that either you were desperate and broke or that you were trying to salvage what you could of your original investment before the whole lot went down the pan along with the company you bought them in.

Could be that the 1.65million of shares are about to be dumped on the market ... anyone got another angle on this ?

And to describe someone that has turned 5 million into 1.65 million cash and 1.65 million in shares of a company that is nose diving as "a leading institutional investor" is a bloody joke.

What they leading in ... wealth destruction ?

22p here we come.

Glad my dosh isn't with that "institutional investor". ;-))

Must be why I do my own stuff now! LOL

When is the agm,if any one can let us know.Thanks

Dunno , when's the 13th next fall on a Friday ?

BioProgress PLC
07 June 2005


Press Release 7 June 2005

BioProgress plc

('BioProgress' or 'the Company')


Update on partnership developments


BioProgress plc (AIM: BPRG; NASDAQ: BPRG), the provider of innovative delivery
mechanisms for the pharmaceutical oral dosage markets, today announces a
progress update on partnership developments.

BioProgress is delighted to announce that the first NROBE(TM) machine for powder
encapsulation has been delivered to its strategic partner FMC BioPolymer ('FMC
'), a business unit of the FMC Corporation (NYSE:FMC). This is a significant
step in the development of the technology, leading towards full scale
production. BioProgress will continue its close collaboration with FMC to
maximise the commercial potential of NROBE(TM).

The global market for oral dose forms is worth several billion US$ and NROBE(TM)
presents a unique delivery solution to this market. FMC BioPolymer is a global
leader in the supply of products and services to the pharmaceutical and life
sciences industries.

FMC Corporation (NYSE:FMC) is a diversified chemical company serving
agricultural, industrial and consumer markets globally for more than a century
with innovative solutions, applications and quality products. The company
employs approximately 5,500 people throughout the world. The company divides
its businesses into three segments: Agricultural Products, Speciality Chemicals
and Industrial Chemicals.

BioProgress also advises that the exclusive option agreement with Wyeth will not
be extended. BioProgress will continue to explore opportunities with Wyeth.
However, in relation to the Company's SWOLLO liquid-fill encapsulation
technology, BioProgress will extend this exciting technology to other partners
so as to fully exploit and commercialise its potential.


- Ends -